Evaluating the Role of SARS-CoV-2 Antibody Levels in the Care of Long COVID Patients Infected with the Omicron Variant - Scorecard - MDSpire

Evaluating the Role of SARS-CoV-2 Antibody Levels in the Care of Long COVID Patients Infected with the Omicron Variant

  • By

  • Marina Kawaguchi

  • Yasue Sakurada

  • Kazuki Tokumasu

  • Yuki Otsuka

  • Yasuhiro Nakano

  • Yui Matsuda

  • Hiroyuki Honda

  • Daisuke Omura

  • Nobuyoshi Matsuki

  • Masanori Furukawa

  • Akihito Higashikage

  • Fumio Otsuka

  • April 22, 2026

  • 0 min

Share

Clinical Scorecard: Evaluating the Role of SARS-CoV-2 Antibody Levels in the Care of Long COVID Patients Infected with the Omicron Variant

At a Glance

CategoryDetail
ConditionLong COVID (LC) - defined as symptoms persisting for at least 3 months post-COVID-19 onset.
Key Mechanisms
Target Population
Care Setting

Key Highlights

  • highlight_2

Guideline-Based Recommendations

Diagnosis

    Management

    • Multidisciplinary approach recommended for managing Long COVID symptoms.
    • Consider specific therapies based on symptomatology.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        275 patients (129 men, 146 women), including 57 unvaccinated.

        Antibody levels reflect immune response and correlate with clinical features.

        Clinical Best Practices

        • additional_recommendation

        References

        Original Source(s)

        Related Content